Based on metabolic modeling analysis, we identified four target genes, namely SOAT1, CRLS1, ACACB, and GPD2, whose inhibition can block the growth of ccRCC tumor cells with relatively low toxicity to normal tissue cells. The gene discussed is CRLS1; the disease is nonpapillary renal cell carcinoma.